CoreAge Rx vs LunaRx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and LunaRx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make LunaRx a bad call — it's best for people seeking english or spanish clinical support who want the actual stack ingredients, complete payment and treatment-transition plan explained. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | LunaRx |
|---|---|---|
| Brief Score | 94/100 (A) | 64/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Selected-stack price unconfirmed Homepage from $139/mo, banner from $199/mo; actual medication/peptide quantities and full payment unconfirmed. Compounded medication, monitoring, bilingual messaging and delivery described as included. FAQ 30-day notice versus terms 48-hour renewal cutoff. Initial order cancellation only within 24 hours before provider-network receipt; delivery claims within 48 hours; returns/disposal wording needs clarification. Full price detailsCompounded semaglutide weekly program offered; complete selected-stack quote unknown; homepage from $139/month while banner says from $199/month, actual medication and included peptide quantities require confirmation |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Selected-stack price unconfirmed Homepage from $139/mo, banner from $199/mo; actual medication/peptide quantities and full payment unconfirmed. Compounded medication, monitoring, bilingual messaging and delivery described as included. FAQ 30-day notice versus terms 48-hour renewal cutoff. Initial order cancellation only within 24 hours before provider-network receipt; delivery claims within 48 hours; returns/disposal wording needs clarification. Full price detailsCompounded tirzepatide weekly program offered; complete selected-stack quote unknown; homepage from $139/month while banner says from $199/month, actual medication and included peptide quantities require confirmation |
| Coverage | US only; restrictions by state, confirmed at intake | Treatment pages advertise nationwide telehealth, while terms limit service to locations where the clinical network operates; confirm actual patient-state and pharmacy access |
| Brand-name access | Not confirmed | The reviewed GLP-1 programs describe compounded treatment; branded drug names in scientific context do not establish a current branded offer. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
LunaRx: Homepage from $139/month versus banner $199; full selected stack quote unconfirmed. Bilingual care and peptide add-ons described. FAQ 30-day versus terms 48-hour renewal notice; initial order cancellation has a separate conditional 24-hour cutoff.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.